It is "Walk Season" here at the Klingbiel home. As most of you know, that means much effort is made to raise money for the Juvenile Diabetes Research Foundation (JDRF). We are asking for your help!
JDRF has made exciting progress with potential therapies to help those who suffer from Type 1 Diabetes or T1D. One such therapy, is an implantable source of insulin cells that would essentially do all the work that the broken Type 1 diabetic’s pancreas will not. Human trials are beginning this year. In Europe, an insulin pump that both reads blood sugar (continuous glucose monitor or CGM) and supplies insulin with only one insertion site is now available. In the US, trials for the artificial pancreas are taking place (this is an insulin pump and CGM that automatically dispenses the correct amount of insulin to match the body’s needs) without the assistance of medical staff on site, which is the next step towards taking this device to market.
You can donate here online, or if you prefer, you can mail your gift check to us at the address listed below. Please make the check out to JDRF and include our name in the “Memo” section.
920 Woodbury Dr. Grand Ledge, MI 48837-2295
Any amount, great or small, helps JDRF get closer to its goal of finding better treatments and a cure for type 1 diabetes. We greatly appreciate your support and will keep you posted on our progress.
The Klingbiel’s and Rozich’s (Steven’s JDRF Jedi)
About JDRF: JDRF is the worldwide leader in funding research to find better treatments and a cure for type 1 diabetes, an autoimmune disease that strikes children and adults suddenly and lasts a lifetime. It sets the global agenda for type 1 diabetes research, and is the largest charitable funder of and advocate for diabetes science worldwide. To date, JDRF has funded more than $1.5 billion in diabetes research, including nearly $107 million in fiscal year 2010.
Your donation will count towards the team's fundraising total. In addition, please give credit to the person that asked for your support to recognize them for their efforts in creating a world without type 1 diabetes (T1D).